View Post

Breast Cancer in Men: Examining Treatment Patterns and Prognostic Factors

In In The News by Barbara Jacoby

By: Tom Greenhalgh From: oncologynurseadvisor.com Male breast cancer accounts for an estimated 1% of breast cancer cases in the United States.1 Due to its relative rarity, few studies have evaluated treatment patterns and prognostic factors in the disease.2 Filling the Research Gap To better understand how clinicians treat breast cancer in men and which factors might lead to better patient …

View Post

Mayo Breast Cancer Vaccine Could Be Available In Less Than A Decade

In Clinical Studies News by Barbara Jacoby

By: Robin Seaton Jefferson From: forbes.com Researchers at Mayo Clinic in Jacksonville, Florida say a vaccine they have developed could be available within eight years that may not only stop the recurrence of breast and ovarian cancers, but prevent them from developing in the first place. “It is reasonable to say that we could have a vaccine within eight years …

View Post

UIC drug crosses blood-brain barrier, now in clinical trials for cancer patients

In Clinical Studies News by Barbara Jacoby

From: today.uic.edu A drug invented at the University of Illinois at Chicago is now being studied in humans as a treatment for difficult-to-treat and chemoresistant cancers including glioblastoma, or GBM, the deadliest type of brain tumor. UIC professor Irina Gaisina, one of the inventors of the drug, has been closely involved in its research and development, which began more than …

View Post

Mayo researchers ID potential new treatment for one type of triple-negative breast cancer

In Clinical Studies News by Barbara Jacoby

Source: Mayo Clinic From: eurekalert.org Mayo Clinic researchers have identified the drug estradiol as a potential new treatment for a subset of women with triple-negative breast cancer. Their findings are published in the Proceedings of the National Academy of Sciences of the United States of America. “Triple-negative breast cancer is a form of breast cancer that lacks expression of estrogen …

View Post

Breast cancer vaccine that could save generations now in clinical trials at Mayo Clinic

In Clinical Studies News by Barbara Jacoby

By: Lena Harris From: kare11.com While the vaccine is still in clinical trials, doctors say they are very excited about it because it seems to be working with few negative side effects. The problem is, studies show less than 5 percent of adults with cancer enroll in trials. Tens of thousands of women die annually from breast cancer, but soon, …

View Post

Mayo Clinic sees hope in breast cancer vaccine

In In The News by Barbara Jacoby

By: Kristin Bender From: fox32chicago.com (KTVU) – Treating breast cancer has long involved addressing two problems: eliminating cancer cells from the tumor and preventing the disease from returning. Experts say the key may be to stimulate and strengthen the body’s immune system to do both jobs. Researchers at the Mayo Clinic in Florida announced they are working on a new …

View Post

Ambry Genetics and Leading Academic Researchers Collaborate to Improve Knowledge of Genetic Risk Factors for Breast Cancer

In In The News by Barbara Jacoby

By: Deepti Babu, MS, CGC From: ambrygen.com New clinical evidence collected from >65,000 women with breast cancer demonstrates 83% of positive test results are found in genes that impact clinical management Multi-gene germline genetic testing allows for efficient analysis, maximizing risk assessment while minimizing the time needed for results. This has been particularly effective for those with a personal and/or …

View Post

Mayo scientists on the trail of a ‘pan cancer’ test

In In The News by Barbara Jacoby

By: Jeremy Olson From: startribune.com Mayo Clinic is in a race against itself on a project that could revolutionize cancer care, as two research teams pursue a “pan cancer” test. Mayo Clinic is in a race against itself on a project that could revolutionize cancer care, as two research teams pursue a “pan cancer” test that could detect the presence …

View Post

Vaccine may prevent progression of DCIS to breast cancer

In In The News by Barbara Jacoby

From: healio.com Researchers at Mayo Clinic received a $3.7 million grant from the U.S. Department of Defense to test a vaccine designed to establish lifelong immunity against the development of breast cancer in women with ductal carcinoma in situ. No methods exist to detect which of the 35% of ductal carcinoma in situ (DCIS) cases will progress to cancer if …